Does LEUPROLIDE Cause Syringe issue? 7,847 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7,847 reports of Syringe issue have been filed in association with LEUPROLIDE (Fensolvi). This represents 11.1% of all adverse event reports for LEUPROLIDE.
7,847
Reports of Syringe issue with LEUPROLIDE
11.1%
of all LEUPROLIDE reports
9
Deaths
12
Hospitalizations
How Dangerous Is Syringe issue From LEUPROLIDE?
Of the 7,847 reports, 9 (0.1%) resulted in death, 12 (0.2%) required hospitalization.
Is Syringe issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 7,847 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
Off label use (2,060)
What Other Drugs Cause Syringe issue?
USTEKINUMAB (2,169)
DEVICE (634)
OCTREOTIDE (621)
RISPERIDONE (540)
GUSELKUMAB (458)
MEDROXYPROGESTERONE (354)
PALIPERIDONE (299)
GOLIMUMAB (269)
OMALIZUMAB (257)
CERTOLIZUMAB PEGOL (255)
Which LEUPROLIDE Alternatives Have Lower Syringe issue Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM